All
Replay
Replay2301
Replay2310
Replay2308
Replay2306
Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.
14:00 | 14:20
Prof. Joseph GLIGOROV
Oncologist, Paris, France
Therapeutic options and systemic therapy.
16:15 | 16:30
Prof. Joseph GLIGOROV
Oncologist, Paris, France
AVAILABLE
Conjugated antibodies.
11:35 | 11:55
Prof. Joseph GLIGOROV
Oncologist, Paris, France
AVAILABLE
New drugs and options in MBC: Are there drugs that must be offered to patients in 2023?
16:55 | 17:15
Prof. Joseph GLIGOROV
Oncologist, Paris, France
AVAILABLE